Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01675921 · ClinicalTrials.gov registry record · NA

Implementation of ACT Through Facebook for Teenagers With Asthma

A NA study of Asthma, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT01675921: Completed NA study of Asthma, sponsored by Massachusetts General Hospital.

NCT01675921 is a NA study of Asthma that has completed, run by Massachusetts General Hospital. The registered enrollment target is 120 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01675921, a NA study of Asthma, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

The investigators hypothesize that at the end of the 12-month trial, teenagers regularly self-monitoring their asthma control with ACT administered through Facebook will have improved ACT scores as compared with teenagers receiving usual care.

Conditions Studied

Interventions

  • OTHER Facebook group

Study Locations (1)

Massachusetts

  • Partners Center for Connected Health - Boston

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2012-09
Est. Completion 2015-04
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT01675921

The ClinicalTrials.gov registry entry for NCT01675921 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (92% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Facebook group is the first listed.

NCT01675921 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01675921 about?

NCT01675921 is a clinical study titled "Implementation of ACT Through Facebook for Teenagers With Asthma". The investigators hypothesize that at the end of the 12-month trial, teenagers regularly self-monitoring their asthma control with ACT administered through Facebook will have improved ACT scores as compared with teenagers receiving usual care.

What is the current status of trial NCT01675921?

This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2012-09. Estimated completion is 2015-04.

What conditions does trial NCT01675921 study?

This clinical trial studies the following conditions: Asthma.

What interventions are being tested in trial NCT01675921?

The interventions under investigation include: Facebook group (OTHER).

Who is sponsoring clinical trial NCT01675921?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01675921 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.